Literature DB >> 2193318

Tumour shrinkage and down staging after preoperative radiation of rectal adenocarcinomas.

A Horn1, I Morild, O Dahl.   

Abstract

In order to analyse the influence of low radiation doses on human rectal adenocarcinomas, gross and microscopical changes after preoperative radiation were compared to controls treated with immediate surgery in a randomised, prospective trial. The X-ray doses given were 31.5 Gy in 3.5 weeks, and the interval between radiation and operation was 2 to 3 weeks. A total of 138 patients having preoperative radiotherapy and 131 controls were analysed. The overall tumour size was reduced after radiation. Complete tumour regression was obtained in six (4.4%) patients. All of these tumours were exophytic and mobile at the initial examination and all were either well or moderately well differentiated. A significant downstaging was found after preoperative radiation. The incidence of positive lymph nodes was 27.5% in the resected specimens in controls and 18.4% after radiation (p less than 0.05). The total number of recurrences was reduced after radiation in stage C2 tumours, but not in the other stages. Preoperative radiation did not influence the histological grade of the tumours. There was no difference between the two randomised groups with respect to 5-year survival or disease-free survival in any histopathological stage.

Entities:  

Mesh:

Year:  1990        PMID: 2193318     DOI: 10.1016/0167-8140(90)90019-s

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  15 in total

1.  Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance.

Authors:  Dietrich Doll; Ralf Gertler; Matthias Maak; Jan Friederichs; Karen Becker; Hans Geinitz; Monika Kriner; Hjalmar Nekarda; Jörg R Siewert; Robert Rosenberg
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

2.  Imunoexpression of Ki-67 and p53 in rectal cancer tissue after treatment with neoadjuvant chemoradiation.

Authors:  Nara Rosana Andrade; Celina Tizuko Fujiyama Oshima; Thiago Simão Gomes; Ricardo Artigiani Neto; Nora Manoukian Forones
Journal:  J Gastrointest Cancer       Date:  2011-03

3.  Hypofractionation radiotherapy for a locally recurrent rectal carcinoma as a treatment for an elderly patient.

Authors:  C I Rodrigues; K H Njo; A B Karim
Journal:  Support Care Cancer       Date:  1993-11       Impact factor: 3.603

4.  SAGES evidence-based guidelines for the laparoscopic resection of curable colon and rectal cancer.

Authors:  Marc Zerey; Lisa Martin Hawver; Ziad Awad; Dimitrios Stefanidis; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2012-12-13       Impact factor: 4.584

5.  Adjuvant and neoadjuvant treatment of resectable, locally advanced, rectal carcinoma with radiation therapy and chemotherapy.

Authors:  Roland B Hawkins
Journal:  Ochsner J       Date:  2002

Review 6.  Radiation treatment for rectal cancer.

Authors:  B J Cummings
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 7.  [Indications for neoadjuvant therapy in rectal carcinoma].

Authors:  F Zimmermann; M Molls
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

8.  Endorectal ultrasound for control of preoperative radiotherapy of rectal cancer.

Authors:  F Glaser; C Kuntz; P Schlag; C Herfarth
Journal:  Ann Surg       Date:  1993-01       Impact factor: 12.969

9.  Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer.

Authors:  Anna Gasinska; Jan Skolyszewski; Tadeusz Popiela; Piotr Richter; Zbigniew Darasz; Krystyna Nowak; Joanna Niemiec; Beata Biesaga; Agnieszka Adamczyk; Krzysztof Bucki; Krzysztof Malecki; Marian Reinfuss; Teresa Kowalska
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

10.  Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma.

Authors:  Iosief Abraha; Cynthia Aristei; Isabella Palumbo; Marco Lupattelli; Stefano Trastulli; Roberto Cirocchi; Rita De Florio; Vincenzo Valentini
Journal:  Cochrane Database Syst Rev       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.